+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AMERISE AMERISE

Amerise Biosciences Share Price

 
66.00% Gain from 52W Low

04 Nov, 2026 4:01 PM (IST)

Amerise Biosciences live price: ₹0.83. It opened at ₹1 vs previous close ₹1; intraday high/low: ₹1/₹1. The 50 & 200 DMA stand at ₹0.80/₹0.80.

Amerise Biosciences Performance

  • Today's Low
  • ₹1
  • Today's High
  • ₹1
  • 52 Week Low
  • ₹1
  • 52 Week High
  • ₹1
  • Open Price₹1
  • Previous Close₹1
  • Volume269,746
  • 50 DMA₹0.80
  • 100 DMA₹0.80
  • 200 DMA₹0.80

Amerise Biosciences Chart

Investment Returns

  • Over 1 Month + 6.41%
  • Over 3 Month -13.54%
  • Over 6 Month + 20.29%
  • Over 1 Year + 29.69%

Smart Investing Starts Here Start SIP with Amerise Biosciences for Steady Growth!

Invest Now

Amerise Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -80.5
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 6
  • P/B Ratio
  • 1
  • Average True Range
  • 0
  • EPS
  • -0
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 54.02
  • MFI
  • 26.91

Latest Stock News Updates

Amerise Biosciences Ltd - 531681 - Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

PFA

Amerise Biosciences Ltd - 531681 - Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th October 2026.

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Friday 30th October 2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and half year ended as on 30th September, 2026. The board meeting commented at 03:45 PM and concluded at 04:15 PM Please take the above intimation in your records. Thanking You,

Amerise Biosciences Ltd - 531681 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Snehjeev Ventures Pvt Ltd

Amerise Biosciences Financials

Amerise Biosciences Technicals

EMA & SMA

Current Price
₹0.83
-0.03 (-3.49%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹0.80
  • 50 Day
  • ₹0.80
  • 100 Day
  • ₹0.80
  • 200 Day
  • ₹0.80

Resistance and Support

0.84 Pivot Speed
  • R3 0.90
  • R2 0.90
  • R1 0.90
  • S1 0.80
  • S2 0.80
  • S3 0.80

Amerise Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-30 Quarterly Results
2026-08-03 Quarterly Results
2026-05-05 Audited Results
2026-02-02 Quarterly Results
2025-11-05 Quarterly Results
Date Purpose Remarks
2003-11-25 Split Sub Division of equity shares from Rs. 10/- to Rs. 1/-

Amerise Biosciences Shareholding Pattern

100%
0%
0%

About Amerise Biosciences

Amerise Biosciences having main objects of ‘manufacture and make buy, sell, import, export, distribute, introduce or otherwise deal in Decorative Boards, Laminates Sheets, Boards and laminates products in India and elsewhere since incorporation. View More
  • NSE Symbol
  • AMERISE
  • BSE Symbol
  • 531681
  • ISIN
  • INE673C01020

Similar Stocks to Amerise Biosciences

Amerise Biosciences FAQs

Amerise Biosciences share price is ₹0 As on 05 November, 2026 | 03:00

The Market Cap of Amerise Biosciences is ₹5.5 Cr As on 05 November, 2026 | 03:00

The P/E ratio of Amerise Biosciences is -80.5 As on 05 November, 2026 | 03:00

The PB ratio of Amerise Biosciences is 1 As on 05 November, 2026 | 03:00

The 52 week High & Low of Amerise Biosciences is ₹1/₹0.5 respectively As on 05 November, 2026 | 03:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23